Nasir, T;
Lee, C;
Lawrence, AS;
Brown, JS;
(2019)
Invasive aspergillosis complicating treatment with tyrosine kinase inhibitors.
BMJ Case Reports
, 12
(1)
10.1136/bcr-2018-226121.
Preview |
Text
Brown Aspergillosis BMJ Case reports 2018.pdf - Accepted Version Download (191kB) | Preview |
Abstract
We describe three cases of pulmonary aspergillosis (PA) in three patients without traditional risk factors for invasive aspergillosis infection, such as prolonged neutropenia or high dose systemic corticosteroid therapy. All three patients developed PA whilst taking tyrosine kinase inhibitors (TKI) and sustained greater clinical improvement once TKI were withdrawn. Our case series supports the theory TKI treatment can increase susceptibility to PA without causing neutropenia. Recognition that TKI treatment may predispose to invasive aspergillosis will allow for rapid recognition of patients of affected patients and more effective management of future cases.
Archive Staff Only
 |
View Item |
